Low‐dose TNF ‐α promotes angiogenesis of oral squamous cell carcinoma cells via TNFR2 /Akt/ mTOR axis
Oral Diseases · 2024
DOI: 10.1111/odi.14802 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, 2024. Verfasst von Shutong Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontology, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University and Shandong Key Laboratory of Ora…. Hauptthemen laut MEDLINE: Receptors, Tumor Necrosis Factor, Type II, Mouth Neoplasms, TOR Serine-Threonine Kinases, Tumor Necrosis Factor-alpha. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 65 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Construction Engineering Special Fund of "Taishan Scholars", Major Innovation Projects in Shandong Province.
Abstract (Originalsprache)
Objectives
To assess the role of TNF‐α/TNFR2 axis on promoting angiogenesis in oral squamous cell carcinoma (OSCC) cells and uncover the underlying mechanisms. Materials and Methods The expression of TNFR2 and CD31 in OSCC tissues was examined; gene expression relationship between TNF‐α/TNFR2 and angiogenic markers or signaling molecules was analyzed; the expression of angiogenic markers, signaling molecules, TNFR1, and TNFR2 in TNF‐α‐stimulated OSCC cells treated with or without TNFR2 neutralizing antibody (TNFR2 Nab) were assessed; the concentration of angiogenic markers in the supernatant of OSCC cells was detected; conditioned mediums of OSCC cells treated with TNF‐α or TNF‐α + TNFR2 Nab were applied to human umbilical vein endothelial cells (HUVECs), followed by tube formation and cell migration assays.
Results
Significantly elevated expression of TNFR2 and CD31 in OSCC tissues was observed. A positive gene expression correlation was identified between TNF‐α/TNFR2 and angiogenic markers or signaling molecules. TNFR2 Nab inhibited the effects of TNF‐α on enhancing the expression of angiogenic factors and TNFR2, the phosphorylation of the Akt/mTOR signaling pathway, HUVECs migration, and tube formation.
Conclusions
TNFR2 Nab counteracts the effect of TNF‐α on OSCC cells through the TNFR2/Akt/mTOR axis, indicating that blocking TNFR2 might be a promising strategy against cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Periodontology, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University and Shandong Key Laboratory of Oral Tissue Regeneration and Shandong Engineering Laboratory for Dental M…
- School of Information and Computer Sciences, Institute for Genomics and Bioinformatics, University of California Irvine, Irvine, California, USA.
- Division of Life Sciences and Medicine, Department of Stomatology, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, Anhui, China.
- Department of Oral and Maxillofacial Surgery, Qilu Hospital of Shandong University, Jinan, Shandong, China.
- Institute of Stomatology, Shandong University, Jinan, Shandong, China.
ORCID-Profile: Wenchuan Liu, Liguo Zhang, Pishan Yang, Chengzhe Yang
Förderung
- National Natural Science Foundation of China
- Construction Engineering Special Fund of "Taishan Scholars"
- Major Innovation Projects in Shandong Province
Zitieren
APA
Li, S., Liu, W., Liu, J., Yang, Z., Zhang, L., Nie, F., Yang, P., Guo, H., & Yang, C. (2024). Low‐dose TNF ‐α promotes angiogenesis of oral squamous cell carcinoma cells via TNFR2 /Akt/ mTOR axis. Oral Diseases. https://doi.org/10.1111/odi.14802
Vancouver
Li S, Liu W, Liu J, Yang Z, Zhang L, Nie F, et al. Low‐dose TNF ‐α promotes angiogenesis of oral squamous cell carcinoma cells via TNFR2 /Akt/ mTOR axis. Oral Diseases. 2024. doi:10.1111/odi.14802
BibTeX
@article{Li2024,
author = {Li, Shutong and Liu, Wenchuan and Liu, Junze and Yang, Zongcheng and Zhang, Liguo and Nie, Fujiao and Yang, Pishan and Guo, Hongmei and Yang, Chengzhe},
title = {Low‐dose TNF ‐α promotes angiogenesis of oral squamous cell carcinoma cells via TNFR2 /Akt/ mTOR axis},
journal = {Oral Diseases},
year = {2024},
doi = {10.1111/odi.14802}
}
EUVIMED